On behalf of its member companies and organizations, the Biotechnology Innovation Organization (“BIO”) extends its appreciation to NIST for considering these comments in response to the agency’s Draft Interagency Guidance Framework for Considering…
On behalf of its member companies and organizations, the Biotechnology Innovation Organization (“BIO”) extends its appreciation to NIST for considering these comments in response to the agency’s Draft Interagency Guidance Framework for Considering…
BIO’s submission is in response to the USPTO’s Request for Comments (88 FR 9492, February 14, 2023)
BIO’s submission is in response to the USPTO’s Request for Comments (88 FR 9492, February 14, 2023)